Bendamustine Accord Stofn fyrir innrennslisþykkni, lausn 2,5 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

bendamustine accord stofn fyrir innrennslisþykkni, lausn 2,5 mg/ml

accord healthcare b.v. - bendamustinum hýdróklóríð - stofn fyrir innrennslisþykkni, lausn - 2,5 mg/ml

Asubtela (Ethinylestradiol/Drospirenon 0,03 mg/3 mg Focus) Filmuhúðuð tafla 3 mg/ 0,03 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

asubtela (ethinylestradiol/drospirenon 0,03 mg/3 mg focus) filmuhúðuð tafla 3 mg/ 0,03 mg

exeltis healthcare s.l. - drospirenonum inn; ethinylestradiolum inn - filmuhúðuð tafla - 3 mg/ 0,03 mg

Sevoflurane Piramal (Sevoflurane) Innöndunargufa, gegndreyptur stabbi 100 % Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

sevoflurane piramal (sevoflurane) innöndunargufa, gegndreyptur stabbi 100 %

piramal critical care b.v. - sevofluranum inn - innöndunargufa, gegndreyptur stabbi - 100 %

Sevoflurane Baxter Innöndunargufa, gegndreyptur stabbi 100 % Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

sevoflurane baxter innöndunargufa, gegndreyptur stabbi 100 %

baxter medical ab* - sevofluranum inn - innöndunargufa, gegndreyptur stabbi - 100 %

Baclofen Sintetica í mænuvökva Innrennslislyf, lausn 2 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

baclofen sintetica í mænuvökva innrennslislyf, lausn 2 mg/ml

sintetica gmbh - baclofenum inn - innrennslislyf, lausn - 2 mg/ml

Cefuroxim Fresenius Kabi Stungulyfs-/innrennslisstofn, lausn 750 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

cefuroxim fresenius kabi stungulyfs-/innrennslisstofn, lausn 750 mg

fresenius kabi ab - cefuroximum natríum - stungulyfs-/innrennslisstofn, lausn - 750 mg

Nipruss Innrennslisstofn, lausn 60 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

nipruss innrennslisstofn, lausn 60 mg

oresund pharma aps - sodium nitroprusside dihydrate - innrennslisstofn, lausn - 60 mg

Virbagen Omega Evrópusambandið - íslenska - EMA (European Medicines Agency)

virbagen omega

virbac s.a. - raðbrigða omega interferón af kattgengu uppruna - Ónæmisörvandi, - dogs; cats - dogsreduction of mortality and clinical signs of parvovirosis (enteric form) in dogs from one month of age. catstreatment of cats infected with feline leukaemia virus (felv) and / or feline immunodeficiency virus (fiv), in non-terminal clinical stages, from the age of nine weeks. in a field study conducted, it was observed that there was:a reduction of clinical signs during the symptomatic phase (four months);a reduction of mortality:in anaemic cats, mortality rate of about 60% at four, six, nine and 12 months was reduced by approximately 30% following treatment with interferon;in non-anaemic cats, mortality rate of 50% in cats infected by felv was reduced by 20% following treatment with interferon. hjá köttum sem sýkt voru af fiv var dauðsföll lágt (5%) og hafði ekki áhrif á meðferðina.

Midazolam Accord Stungulyf/innrennslislyf, lausn 5 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

midazolam accord stungulyf/innrennslislyf, lausn 5 mg/ml

accord healthcare b.v. - midazolamum hýdróklóríð - stungulyf/innrennslislyf, lausn - 5 mg/ml

Cefuroxim Fresenius Kabi Stungulyfs-/innrennslisstofn, lausn 1500 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

cefuroxim fresenius kabi stungulyfs-/innrennslisstofn, lausn 1500 mg

fresenius kabi ab - cefuroximum natríum - stungulyfs-/innrennslisstofn, lausn - 1500 mg